Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jun 23;11(3):00209-2025.
doi: 10.1183/23120541.00209-2025. eCollection 2025 May.

Real-world evidence on biologic use in paediatric asthma: there but not there yet?

Wenjia Chen  1
Affiliations
Editorial

Real-world evidence on biologic use in paediatric asthma: there but not there yet?

Wenjia Chen. ERJ Open Res. .

Abstract

Persistent unmet needs in children with severe asthma on biologics call for precision medicine to optimise treatment, address steroid toxicity, and ensure cost-effective, sustainable care through national registries and health technology assessments https://bit.ly/4deHEpq.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: W. Chen serves as an Early Career Investigator Delegate for the AstraZeneca Global Respiratory Leadership Forum. However, AstraZeneca had no role in the writing, review, or approval of this editorial, and no financial support was provided for this work.

References

    1. Global Initiative for Asthma . Global Strategy for Asthma Management and Prevention, 2024. Available from https://ginasthma.org
    1. Alhossan A, Lee CS, MacDonald K, et al. “Real-life” effectiveness studies of omalizumab in adult patients with severe allergic asthma: meta-analysis. J Allergy Clin Immunol Pract 2017; 5: 1362–1370. doi: 10.1016/j.jaip.2017.02.002 - DOI - PubMed
    1. Nair P, Pizzichini MMM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360: 985–993. doi: 10.1056/NEJMoa0805435 - DOI - PubMed
    1. Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet Lond Engl 2012; 380: 651–659. doi: 10.1016/S0140-6736(12)60988-X - DOI - PubMed
    1. Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 2014; 371: 1198–1207. doi: 10.1056/NEJMoa1403290 - DOI - PubMed

Publication types

LinkOut - more resources